Coronavirus Disease 2019 (COVID-19)
Although mix-ups appear to be rare, these errors in vaccine administration can have serious consequences to patients, including lack of proper protection from a disease, the need to revaccinate, diminished trust in vaccines, and increased healthcare costs.
The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for substandard and falsified (SSF) COVID-19 vaccines, particularly in low- and middle-income countries. At the U.S.
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
USP’s success in its mission to improve global public health through creation of standards and related programs depends in large part on the work of volunteers.
USP’s recently released COVID-19 Vaccine Handling Toolkit is helping to fill critical operational efficiency gaps that practice settings have identified in vaccine administration.
The COVID-19 pandemic has presented unprecedented challenges around the world, including to national public health systems and the international biopharmaceutical industry.
Another public health crisis looms in the wake of the COVID-19 pandemic.
Recent politicization of the COVID-19 vaccine development and approval process has led to a concerning loss of confidence in vital governmental institutions. Each day that goes by, the picture seems to grow darker. Politicians criticize scientists without cause.